Search Results - "Woo, Wayne"

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine by Underwood, Eddie, Dunkle, Lisa M., Madhi, Shabir A., Gay, Cynthia L., Heath, Paul T., Kotloff, Karen L., Smith, Katherine, Chau, Gordon, Galbiati, Shirley, McGarry, Alice, Woo, Wayne, Cho, Iksung, Alves, Katia, Áñez, Germán, Bennett, Chijioke, Shinde, Vivek, Fries, Louis, Mallory, Raburn M., Glenn, Gregory M., Toback, Seth

“…The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity…”
Get full text

Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial by Fong, Youyi, Huang, Yunda, Benkeser, David, Carpp, Lindsay N., Áñez, Germán, Woo, Wayne, McGarry, Alice, Dunkle, Lisa M., Cho, Iksung, Houchens, Christopher R., Martins, Karen, Jayashankar, Lakshmi, Castellino, Flora, Petropoulos, Christos J., Leith, Andrew, Haugaard, Deanne, Webb, Bill, Lu, Yiwen, Yu, Chenchen, Borate, Bhavesh, van der Laan, Lars W. P., Hejazi, Nima S., Randhawa, April K., Andrasik, Michele P., Kublin, James G., Hutter, Julia, Keshtkar-Jahromi, Maryam, Beresnev, Tatiana H., Corey, Lawrence, Neuzil, Kathleen M., Follmann, Dean, Ake, Julie A., Gay, Cynthia L., Kotloff, Karen L., Koup, Richard A., Donis, Ruben O., Gilbert, Peter B.

Get full text

A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection by Zhu, Mingzhu, Cloney-Clark, Shane, Feng, Sheau-Line, Parekh, Anand, Gorinson, Drew, Silva, David, Skonieczny, Paul, Wilson, Adjele, Kalkeri, Raj, Woo, Wayne, Cai, Miranda R, Fries, Louis, Glenn, Greg, Plested, Joyce S

“…As the COVID-19 pandemic continues, variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge. Immunogenicity evaluation of…”
Get full text

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico by Dunkle, Lisa M, Kotloff, Karen L, Gay, Cynthia L, Áñez, Germán, Adelglass, Jeffrey M, Barrat Hernández, Alejandro Q, Harper, Wayne L, Duncanson, Daniel M, McArthur, Monica A, Florescu, Diana F, McClelland, R. Scott, Garcia-Fragoso, Veronica, Riesenberg, Robert A, Musante, David B, Fried, David L, Safirstein, Beth E, McKenzie, Mark, Jeanfreau, Robert J, Kingsley, Jeffrey K, Henderson, Jeffrey A, Lane, Dakotah C, Ruíz-Palacios, Guillermo M, Corey, Lawrence, Neuzil, Kathleen M, Coombs, Robert W, Greninger, Alex L, Hutter, Julia, Ake, Julie A, Smith, Katherine, Woo, Wayne, Cho, Iksung, Glenn, Gregory M, Dubovsky, Filip

“…NVX-CoV2373 is a vaccine containing a full-length stabilized recombinant spike protein trimer that is administered in two doses 3 weeks apart along with a…”
Get full text

2337. Immunogenicity and Safety of a Heterologous Booster Dose of Omicron Subvariant (BA.1 and BA.5) and Bivalent SARS-CoV-2 Recombinant Spike Protein Vaccines: A Phase 3, Randomized, Clinical Trial by Bennett, Chijioke, Woo, Wayne, Marcheschi, Alex, Mallory, Raburn M

“…Abstract Background Currently circulating Omicron subvariants contain mutations permitting evasion of neutralization with prototype vaccines. Novel Omicron…”
Get full text

149: Outcomes of Low Tidal Volume Ventilation in COVID-19 Intubated Patients by DelPrete, Benjamin, Chintalapani, Sreenidhi, Varghese, Reshma, Habboosh, Noor, Woo, Wayne, Yamane, David, Williams, Jeffrey

Get full text

292: Do COVID-19 Patients Who Receive High-Flow Nasal Cannula Have More Comorbidities and Worse Outcomes? by Payette, Christopher, Hayrapetian, Laurie, Okezue, Chisom, Chintalapani, Sreenidhi, Woo, Wayne, Al-Mashat, Mustafa, Yamane, David

Get full text

139: Is Age Just a Number? Age Versus Comorbidities as Predictor of Mortality in COVID-19 by Pierce, Ayal, Woo, Wayne, Benjenk, Ivy, Karunakaran, Jehshua, Ratnaseelan, Aarane, Heinz, Eric, Yamane, David

Get full text

Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine by Follmann, Dean, Mateja, Allyson, Fay, Michael P, Magaret, Craig A, Huang, Yunda, Fong, Youyi, Angier, Heather, Nason, Martha, Gay, Cynthia L, Kotloff, Karen, Woo, Wayne, Cho, Iksung, Dunkle, Lisa M

“…Protein-based vaccines for coronavirus disease 2019 (COVID-19) provide a traditional vaccine platform with long-lasting protection for non-severe acute…”
Get full text

291: Does Intubation of COVID-19 Patients Save Lives? A Descriptive Analysis of a Prospective Registry by Pierce, Ayal, Mulcahy, Collin, Powell, Alva, Cruz, Philip Dela, Woo, Wayne, Tronnier, Amy, Benjenk, Ivy, Yamane, David

Get full text

NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial by Marchese, Anthony M., Zhou, Xiang, Kinol, John, Underwood, Eddie, Woo, Wayne, McGarry, Alice, Beyhaghi, Hadi, Áñez, Germán, Toback, Seth, Dunkle, Lisa M.

“…PREVENT-19, the pivotal phase 3 trial of the Novavax adjuvanted, recombinant spike protein COVID-19 vaccine (NVX-CoV2373), demonstrated that the vaccine was…”
Get full text

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial by Fong, Youyi, Huang, Yunda, Benkeser, David, Carpp, Lindsay N., Áñez, Germán, Woo, Wayne, McGarry, Alice, Dunkle, Lisa M., Cho, Iksung, Houchens, Christopher R., Martins, Karen, Jayashankar, Lakshmi, Castellino, Flora, Petropoulos, Christos J., Leith, Andrew, Haugaard, Deanne, Webb, Bill, Lu, Yiwen, Yu, Chenchen, Borate, Bhavesh, van der Laan, Lars W. P., Hejazi, Nima S., Randhawa, April K., Andrasik, Michele P., Kublin, James G., Hutter, Julia, Keshtkar-Jahromi, Maryam, Beresnev, Tatiana H., Corey, Lawrence, Neuzil, Kathleen M., Follmann, Dean, Ake, Julie A., Gay, Cynthia L., Kotloff, Karen L., Koup, Richard A., Donis, Ruben O., Gilbert, Peter B.

“…In the PREVENT-19 phase 3 trial of the NVX-CoV2373 vaccine (NCT04611802), anti-spike binding IgG concentration (spike IgG), anti-RBD binding IgG concentration…”
Get full text

154: Staving Off Intubation: Characteristics of Outcomes in Early Versus Delayed Intubation in COVID-19 by Pierce, Ayal, Payette, Christopher, DelPrete, Benjamin, Woo, Wayne, Benjenk, Ivy, Chintalapani, Sreenidhi, Bakizada, Zayna, Johnson, Sheryl, Habboosh, Noor, Varghese, Reshma, Yamane, David

Get full text

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults by Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan E, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne E, Oostvogels, Lidia, Curran, Desmond

“…Abstract Background Herpes zoster may significantly impact quality of life (QoL) in older adults. The recombinant zoster vaccine (RZV) is efficacious in adults…”
Get full text

Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial by Bennett, Chijioke, Rivers, E Joy, Woo, Wayne, Bloch, Mark, Cheung, King, Griffin, Paul, Mohan, Rahul, Deshmukh, Sachin, Arya, Mark, Cumming, Oscar, Neville, A Munro, Pardey, Toni McCallum, Plested, Joyce S, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Buchanan, Agi, Marcheschi, Alex, Swan, Jennifer, Smith, Gale, Cho, Iksung, Glenn, Gregory M, Walker, Robert, Mallory, Raburn M

“…Mutations present in emerging SARS-CoV-2 variants permit evasion of neutralization with prototype vaccines. A novel Omicron BA.1 subvariant-specific vaccine…”
Get full text

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age by Díez-Domingo, Javier, Sáez-Llorens, Xavier, Rodriguez-Weber, Miguel A, Epalza, Cristina, Chatterjee, Archana, Chiu, Cheng-Hsun, Lin, Chien-Yu, Berry, Andrea A, Martinón-Torres, Federico, Baquero-Artigao, Fernando, Langley, Joanne M, Ramos Amador, José T, Domachowske, Joseph B, Huang, Li-Min, Chiu, Nan-Chang, Esposito, Susanna, Moris, Philippe, Lien-Anh Nguyen, Thi, Nikic, Vanja, Woo, Wayne, Zhou, Yingjun, Dieussaert, Ilse, Leach, Amanda, Gonzalez Lopez, Antonio, Vanhoutte, Nicolas

“…Abstract Background Safe and effective respiratory syncytial virus (RSV) vaccines remain elusive. This was a phase I/II trial (NCT02927873) of ChAd155-RSV, an…”
Get full text

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study by Kim, Joon Hyung, Drame, Mamadou, Puthanakit, Thanyawee, Chiu, Nan-Chang, Supparatpinyo, Khuanchai, Huang, Li-Min, Chiu, Cheng-Hsun, Chen, Po-Yen, Hwang, Kao-Pin, Danier, Jasur, Friel, Damien, Salaun, Bruno, Woo, Wayne, Vaughn, David W., Innis, Bruce, Schuind, Anne

“…This phase 2 observer-blind, randomized, multicenter, dose-ranging study evaluated immunogenicity and safety of different formulations of an AS03-adjuvanted…”
Get full text

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study by Kim, Joon Hyung, Drame, Mamadou, Puthanakit, Thanyawee, Chiu, Nan-Chang, Supparatpinyo, Khuanchai, Huang, Li-Min, Chiu, Cheng-Hsun, Chen, Po-Yen, Hwang, Kao-Pin, Danier, Jasur, Friel, Damien, Salaun, Bruno, Woo, Wayne, Vaughn, David W., Innis, Bruce, Schuind, Anne

Get full text

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial by Bennett, Chijioke, Woo, Wayne, Bloch, Mark, Cheung, King, Griffin, Paul, Mohan, Rahul, Deshmukh, Sachin, Arya, Mark, Cumming, Oscar, Neville, A Munro, McCallum Pardey, Toni G, Plested, Joyce S, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Marcheschi, Alex, Swan, Jennifer, Smith, Gale, Cho, Iksung, Glenn, Gregory M, Walker, Robert, Mallory, Raburn M, Anderson, Anna, Ang, Mary, Barnes, Timothy, Bassin, Michelle, Bessey, Kate, Bowler, Simon, Bull, Sheetal, Burr, Lucy, Burton, Robert, Byrne, Michelle, Carroll, Robert, Chee, Nicholas, Choy, Aaron, Clark, Malcolm, Dalebout, Marije, De Wet, Peter, Deshmukh, Kshama, Diez Alvarez, Sergio, Douglas, Dominic, Engelander, Jacqueline, Evangelista, Carla, Game, Stuart, Glass, Noor, Gunner, Elizabeth, Han, Jennifer, Harrison, Michael, Hing Kiang, Jason Doong, Hlaing, Thazin, Joshi, Divyansh, Joyce, Sheree, Kaluhin, Karen, Kavic, Milanka, Kononov, Juliana, Lee, Gary, Lee, Wei-I, Leelasena, Indika, Leong, Esmond, Lim, Ivan, Lister, Graham, Loh, Denissa, Magdy, Mary, Maggs, Callum, Mammoottil, Amith, McCarthy, Shannon, McKay, Nicole, Melek, Mariah, Michael Barnett, Adrian, Mohan, Rahul, Moore, Andrew, Moore, Amanda, Murdoch, Louise, Napier-Flood, Fiona, Narsai, Ushma, Neville, Alexander, Nguyen, Paul, Odarchenko, Ekaterina, Pardey, Toni, Quan, Dick, Ranagsinghe, Ushank, Rasalam, Roy, Rayar, Shiva, Ruthnam, Gonasagaran Jay, Seet, Pi, Smith, Deon, Srilakshmanan, Krishna, Taggart, Angela, Tiong, Florence, Toh, Boon, Ujvary, Eniko, Wallace, Stephanie, Wolf, Rebecca, Wong, Ian, Yoo, Hye, Young, Rhys

“…SARS-CoV-2 variants evade immunity despite vaccination with prototype COVID-19 vaccines or previous infection. The 2019nCoV-311 (part 2) study is evaluating…”
Get full text

Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials by Turley, Christine B., Tables, LaKesha, Fuller, Trevon, Sanders, Lisa J., Scott, Hyman, Moodley, Amaran, Woodward Davis, Amanda, Leav, Brett, Miller, Jacqueline, Schoemaker, Kathryn, Vandebosch, An, Sadoff, Jerald, Woo, Wayne, Cho, Iksung, Dunkle, Lisa M., Li, Sijia, van der Laan, Lars, Gilbert, Peter B., Follmann, Dean, Jaynes, Holly, Kublin, James G., Baden, Lindsey R., Goepfert, Paul, Kotloff, Karen, Gay, Cynthia L., Falsey, Ann R., El Sahly, Hana M., Sobieszczyk, Magdalena E., Huang, Yunda, Neuzil, Kathleen M., Corey, Lawrence, Grinsztejn, Beatriz, Gray, Glenda, Rouphael, Nadine, Luedtke, Alex

“…•Age, sex, and race/ethnicity do not affect efficacy against symptomatic COVID-19.•Common underlying health conditions also do not impact vaccine…”
Get full text